HOME › Press Releases › Home Healthcare Market worth 349.8 Billion USD by 2020
Home Healthcare Market worth 349.8 Billion USD by 2020
The report “Home Healthcare Market by Product (BP & Heart Rate Monitor, Ovulation Kit, HIV Test, ECG, EKG, Nebulizer, Hearing Aids, Pedometer, Cane, Walker, Wheelchairs), Software, Services (Rehabilitation, Skilled, Hospice), & Telehealth - Global Forecasts to 2020”, analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia, and the Rest of the World (RoW).
Browse 306 tables and 63 figures spread through 350 pages and in-depth TOC on "Home Healthcare Market by Product (BP & Heart Rate Monitor, Ovulation Kit, HIV Test, ECG, EKG, Nebulizer, Hearing Aids, Pedometer, Cane, Walker, Wheelchairs), Software, Services (Rehabilitation, Skilled, Hospice), & Telehealth - Global Forecasts to 2020"
Early buyers will receive 10% customization on reports.
The global home healthcare market is expected to reach USD 349.8 Billion by 2020 from USD 227.5 Billion in 2015, at a CAGR of 9.0% during the forecast period.
The growth of this market is mainly driven by factors such as rising geriatric population across the globe, growing need of cost-effective healthcare delivery due to increasing healthcare costs, rising incidences of chronic diseases, and technological advancements in devices. However, changing reimbursement policies, limited insurance coverage and risks to personal safety of home care workers are the factors restraining the growth of this market to a certain extent.
The report segments the home healthcare market based on products, services, software, telehealth, and region. Based on products, the market is segmented into testing, screening and monitoring products; therapeutic products; and mobility care products. The testing, screening, and monitoring products segment is expected to account for the largest share of the home healthcare market, by product, in 2015. The rising emphasis on preventive medicine is expected to boost the growth of the home healthcare testing, monitoring, and screening devices market. The potential to reduce healthcare complications and ensure the portability of devices with high accuracy is expected to create a significant demand for monitoring and testing devices. Moreover, with the rising number of patients suffering from chronic diseases in many countries across the globe, the demand for these products is increasing.
The telehealth market is poised to grow at the highest CAGR during the forecast period, owing to the increasing adoption and utilization of telecommunication in providing care.
Based on region, the home healthcare market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is further subsegmented into the U.S. and Canada; while Europe is further subsegmented into Germany, the U.K., France, Italy, Spain, Russia, and Rest of Europe (RoE). In 2015, North America is expected to dominate the market, followed by Europe. The converging trends of aging population, technological advancements, and favorable reimbursement policies are driving the home healthcare market in North America. However, Asia is poised to be the fastest-growing region during the forecast period. Factors such as rising geriatric population, increasing adoption of innovative techniques, increasing disposable income levels, expansion of home healthcare companies in this region, rising awareness about home healthcare, and increasing need for affordable healthcare delivery systems will drive the growth of the Asian market.
The home healthcare market is a fragmented market, with several big and emerging players.
Key market players include Philips Healthcare (Netherlands), Kindred Healthcare (U.S.), Linde Group (Germany), Almost Family Inc. (U.S.), Abbott Laboratories (U.S.), LHC Group (U.S.), Johnson & Johnson (U.S.), A&D Company (Japan), Amedisys Inc. (U.S.), Fresenius SE & Co. KGaA (Germany), Omron Healthcare (Japan), McKesson Corporation (U.S.), Apria Healthcare Group (U.S.), Kinnser Software, Inc. (U.S.), and Roche Holdings AG (Switzerland).
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India